يعرض 1 - 10 نتائج من 304 نتيجة بحث عن '"ER, estrogen receptor"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1

    المصدر: Radiology Case Reports, Vol 16, Iss 7, Pp 1718-1726 (2021)
    Radiology Case Reports

  2. 2

    المصدر: Saudi Journal of Biological Sciences
    Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6289-6296 (2021)

  3. 3

    المصدر: Saudi Pharmaceutical Journal : SPJ
    Saudi Pharmaceutical Journal, Vol 29, Iss 7, Pp 656-669 (2021)

  4. 4

    المصدر: Advanced Drug Delivery Reviews

    مصطلحات موضوعية: ICAM1, Intercellular adhesion molecule–1, PLA, Poly(lactide), GEMM, Genetically modified mouse model, RAG, Rag-deficient, 02 engineering and technology, Metastasis, CCPM, Core-crosslinked block copolymer micelle, TME, Tumor microenvironment, TAM, Tumor-associated macrophages, Breast cancer, NIR, Near-infrared, Th2, Type 2 T helper, NK, Natural killer, AGM, Aminoglutethimide, Medicine, NF1, Neurofibromin 1, BRCA1, Breast cancer type 1 susceptibility protein, SPIO, Superparamagnetic iron oxide nanoparticle, 0303 health sciences, education.field_of_study, ERS1, Estrogen receptor gene, BRCA2, Breast cancer type 2 susceptibility protein, Organoids, CHEK2, Checkpoint kinase 2, Patient-derived xenografts, Nanomedicine, PTBPC, Poly(2‐((tert‐butoxycarbonyl)amino)‐3‐propyl carbonate, DOX, Doxorubicin, 0210 nano-technology, PDOX, Patient-derived organoid-derived xenograft, TNBC, Triple negative breast cancer, NOG, NOD/Shi-scid/γc−/− null, FITC, Fluorescein isothiocyanate, Antineoplastic Agents, 2D, Two-dimensional, MMDOX, Doxorubicin-loaded mixed micelles, Article, NOD-SCID, non-obese diabetic-severe combined immunodeficient, WHO, World Health Organization, FA, Folic acid, PyMT, Polyoma middle tumor-antigen, 03 medical and health sciences, HPMA, Hydroxypropyl methacrylamide, Drug Development, NMU, N-methyl-n-nitrosourea, Humans, SCID, Severe combined immunodeficient, education, WAP, Whey acidic protein, Immune status, MDR1, Multidrug resistance protein 1, PTEN, Phosphatase and tensin homolog, pDNA, Plasmid desoxyribonucleic acid, AuNR, Gold nanorod, medicine.disease, NP, Nanoparticle, VIP, Vasoactive intestinal peptide, Clinical trial, PLGA, poly(lactide-co-glycolide), Nanoparticles, HER2, Epidermal growth factor receptor 2, MMP, Metallopeptidases, Th1, Type 1 T helper, PGA, Poly-L-glutamic acid, Biomarkers, ROS, Reactive oxygen species, IHC, Immunohistochemistry, MMTV, Mouse mammary tumor virus, IO, Iron oxide, IONP, Iron oxide nanoparticle, Pharmaceutical Science, TP53, tumor protein p53, Bioinformatics, ATM, Ataxia-telangiectasia mutated, PALB2, Partner and localizer of BRCA2, Drug Delivery Systems, NSG, NOD scid gamma, uPAR, Urokinase plasminogen activator receptor, PDNA, Plasmid DNA, GSH, Glutathione, LTR, Long terminal repeat, Drug Carriers, EPR, Enhanced permeability and retention, PPTT, Plasmonic photothermal therapy, TPGS, D-α-tocopheryl polyethylene glycol 1000 succinate, DC, Dendritic cells, HIF1α, Hypoxia-inducible factor 1 alpha, MEF, Mouse embryonic fibroblasts, CAF, Cancer-associated fibroblasts, PR, Progesterone receptor, 021001 nanoscience & nanotechnology, Nanomedicines, Animal models, ER, Estrogen receptor, Nude, Athymic nude, DMBA, 7,12-dimethylbenzantracene, PEG, Polyethylene glycol, Female, MUC1, Mucin 1, QbD, Quality by design, 3D, Three-dimensional, PDX, Patient-derived xenograft, Population, Breast Neoplasms, Enhanced permeability and retention effect, Pre-clinical models, CSC, Cancer stem cells, ALOX5, Arachidonate 5-lipoxygenase, iPSC, induced pluripotent stem cells, ECM, Extracellular matrix, ComputingMethodologies_COMPUTERGRAPHICS, 030304 developmental biology, PI3KCA, Phosphatidylinositol 3-kinase, business.industry, SSMM, Sterically-stabilized mixed phospholipid nanomicelle, Cancer, FDA, Food and Drug Administration, PIMs, Porcine pulmonary intravascular macrophages, EGFR, Epithelial growth factor receptor, CDX, Cell-derived xenograft, STK11, Serine/Threonine Kinase 11, business

  5. 5
  6. 6
  7. 7
  8. 8

    المصدر: Toxicology Reports, Vol 8, Iss, Pp 1002-1007 (2021)
    Toxicology Reports

  9. 9

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 1, Pp 30-54 (2021)
    Acta Pharmaceutica Sinica. B

    مصطلحات موضوعية: ER, estrogen receptor, Review, PI3K, phosphatidylinositol 3-hydroxy kinase, 0302 clinical medicine, PROTAC, proteolysis targeting chimera, Medicine, HER2, human epidermal growth factor receptor 2, Selectivity, General Pharmacology, Toxicology and Pharmaceutics, AML, acute myeloid leukemia, Cancer, 0303 health sciences, integumentary system, biology, Kinase, CRPC, castration-resistant prostate cancer, CDKs, cyclin-dependent kinases, MM, multiple myeloma, ORR, overall response rates, Cell cycle, CPU, China Pharmaceutical University, PFS, progression-free survival, FLT, fms-like tyrosine kinase, 030220 oncology & carcinogenesis, STATs, signal transducers and activators of transcription, PDK1, 3-phosphoinositide-dependent protein kinase 1, biological phenomena, cell phenomena, and immunity, JAK, janus kinase, AKT, protein kinase B, PROTAC, 03 medical and health sciences, Cyclin-dependent kinase, NSCLC, non-small cell lung cancer, MCL, mantle cell lymphoma, CDK4/6, 030304 developmental biology, SPH, Shanghai Pharmaceuticals Holding Co., Ltd, Cell growth, business.industry, ERK, extracellular regulated protein kinases, RB, retinoblastoma protein, lcsh:RM1-950, Proteolysis targeting chimera, CIP/KIP, cyclin-dependent kinase inhibitor 1/kinase inhibitory protein, CKIs, cyclin-dependent kinase inhibitors, PR, progesterone receptor, INK4, inhibitors of CDK4, medicine.disease, Clinical trial, FDA, U.S. Food and Drug Administration, enzymes and coenzymes (carbohydrates), lcsh:Therapeutics. Pharmacology, UNISA, University of South Australia, Drug resistance, Cancer cell, biology.protein, Cancer research, business

  10. 10

    المصدر: The Breast : Official Journal of the European Society of Mastology
    Breast, Vol 54, Iss, Pp 139-147 (2020)

    مصطلحات موضوعية: Oncology, Neoplasm, Residual, Databases, Factual, Survival, ER, estrogen receptor, medicine.medical_treatment, LRR, locoregional recurrence, Mastectomy, Segmental, cT, clinical tumor stages, Cohort Studies, TM, total mastectomy, Breast cancer, 0302 clinical medicine, WBRT, whole breast radiation therapy, Breast-conserving surgery, HER2, human epidermal growth factor receptor 2, Breast, Registries, 030212 general & internal medicine, Stage (cooking), Preoperative systemic therapy, ALND, axillary lymph node dissection, DM, distant metastasis, PST, preoperative systemic therapy, CCI, Charlson comorbidity index, Carcinoma, Ductal, Breast, Hazard ratio, RT, radiation therapy, General Medicine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Combined Modality Therapy, pCR, pathological complete response, BRT, breast radiation therapy, Treatment Outcome, Chemotherapy, Adjuvant, TCRD, Taiwan Cancer Registry database, IIT, intention-to-treat, 030220 oncology & carcinogenesis, AJCC, American Joint Committee on Cancer, Regression Analysis, Female, Original Article, Cohort study, Adult, medicine.medical_specialty, Whole breast radiation therapy, Taiwan, Breast Neoplasms, N, nodal, cN, clinical nodal stages, ypT, pathological tumor stages after preoperative systemic therapy, lcsh:RC254-282, Disease-Free Survival, OS, overall survival, Young Adult, 03 medical and health sciences, ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification, SNLB, sentinel lymph node biopsy, Internal medicine, Stages, medicine, Humans, Neoplasm Staging, Proportional Hazards Models, IDC, invasive intraductal carcinoma, Proportional hazards model, business.industry, Antineoplastic Protocols, ypN, pathological nodal stages after preoperative systemic therapy, PR, progesterone receptor, T, tumor, HRs, hazard ratios, medicine.disease, CIs, confidence intervals, Confidence interval, Radiation therapy, Radiotherapy, Adjuvant, Surgery, Lymph Nodes, Neoplasm Recurrence, Local, BCS, breast-conserving surgery, business